Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) closed the day trading at $3.71 down -6.31% from the previous closing price of $3.96. In other words, the price has decreased by -$6.31 from its previous closing price. On the day, 2.57 million shares were traded. RCKT stock price reached its highest trading level at $3.955 during the session, while it also had its lowest trading level at $3.685.
Ratios:
For a better understanding of RCKT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.30 and its Current Ratio is at 7.30. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
On August 20, 2025, BofA Securities Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $10.
BofA Securities Downgraded its Buy to Neutral on July 25, 2025, while the target price for the stock was maintained at $4.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 02 ’26 when Bjork Elisabeth bought 10,000 shares for $3.44 per share. The transaction valued at 34,400 led to the insider holds 50,000 shares of the business.
Schwartz Jonathan David sold 2,545 shares of RCKT for $7,592 on Nov 18 ’25. The insider now owns 299,064 shares after completing the transaction at $2.98 per share. On Nov 18 ’25, another insider, Shah Gaurav, who serves as the CEO of the company, sold 6,276 shares for $2.98 each. As a result, the insider received 18,721 and left with 778,296 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 401504448 and an Enterprise Value of 203791472.
Stock Price History:
The Beta on a monthly basis for RCKT is 0.48, which has changed by -0.6159069 over the last 52 weeks, in comparison to a change of 0.15507638 over the same period for the S&P500. Over the past 52 weeks, RCKT has reached a high of $11.45, while it has fallen to a 52-week low of $2.19. The 50-Day Moving Average of the stock is 10.32%, while the 200-Day Moving Average is calculated to be -3.87%.
Shares Statistics:
Over the past 3-months, RCKT traded about 2.11M shares per day on average, while over the past 10 days, RCKT traded about 2224150 shares per day. A total of 108.21M shares are outstanding, with a floating share count of 99.69M. Insiders hold about 7.89% of the company’s shares, while institutions hold 86.13% stake in the company. Shares short for RCKT as of 1767139200 were 12743607 with a Short Ratio of 6.04, compared to 1764288000 on 11029132. Therefore, it implies a Short% of Shares Outstanding of 12743607 and a Short% of Float of 22.860001.
Earnings Estimates
Rocket Pharmaceuticals Inc (RCKT) is currently under the scrutiny of 13.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.44, with high estimates of -$0.37 and low estimates of -$0.52.
Analysts are recommending an EPS of between -$1.66 and -$2.19 for the fiscal current year, implying an average EPS of -$2.02. EPS for the following year is -$1.29, with 12.0 analysts recommending between $0.69 and -$1.83.
